NCT02951637 2016-11-01Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled TrialShanghai Chest HospitalPhase 2 Unknown300 enrolled
NCT01502202 2012-06-20Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never SmokersNational Cancer Center, KoreaPhase 2 Unknown162 enrolled